Question 1

What is Bristol-Myers Squibb's P/B ratio?

Accepted Answer

Bristol-Myers Squibb (BMY) P/B ratio is 5.8× as of June 5, 2026. The ratio is calculated by dividing market capitalisation by book value of equity, using USD-normalised financials (IAS 21 exchange-rate translation for non-USD reporters).

Question 2

How is the P/B ratio calculated?

Accepted Answer

P/B = Market Capitalisation ÷ Book Value of Equity (most recent quarterly shareholders' equity), or equivalently Share Price ÷ Book Value Per Share. All inputs are sourced from audited GAAP/IFRS filings and translated to USD using period-end exchange rates so the multiple is comparable across companies and currencies.

Question 3

What is the P/B ratio?

Accepted Answer

The price-to-book (P/B) ratio compares a company's market capitalisation to its book value of equity (total shareholders' equity) on the most recent quarterly balance sheet. It is calculated as market cap ÷ book value of equity (equivalent to share price ÷ book value per share). A P/B below 1× implies the market values the business below its accounting net worth; values well above 1× reflect intangible assets, brand value, or a high return on equity.

Question 4

What is a good P/B ratio for Bristol-Myers Squibb?

Accepted Answer

A "good" P/B depends on the business model. Banks, insurers, and other capital-heavy financials typically trade near 1×; asset-light technology and consumer-brand companies can sustainably trade at 5×+ because much of their value is intangible. P/B is most informative when paired with return on equity (ROE). For Bristol-Myers Squibb specifically, the relevant sector benchmark is the current sector median of 3.4×.

Question 5

Is Bristol-Myers Squibb's P/B ratio high or low?

Accepted Answer

Bristol-Myers Squibb's P/B ratio of 5.8× is above its own 5-year average of 5.1× and above the sector median of 3.4×. That places the current reading at the 78th percentile of its 10-year history. A higher multiple usually reflects stronger expected growth, lower perceived risk, or higher returns on capital; a lower multiple reflects the opposite.

Question 6

What is Bristol-Myers Squibb's historical P/B ratio range?

Accepted Answer

In the available daily series, Bristol-Myers Squibb (BMY) P/B ratio has ranged from a low of 2.4× in 2019 to a high of 10.9× in 2001. The 5-year average is 5.1× and the 5-year median is 4.9×.

Question 7

What was Bristol-Myers Squibb's P/B ratio in 2025?

Accepted Answer

Bristol-Myers Squibb (BMY) P/B ratio at the end of 2025 was 6.0×. Annual values reflect the multiple on the last trading day of each calendar year, using the trailing twelve-month book value figure available at that date.

Question 8

Why does Bristol-Myers Squibb's P/B ratio change over time?

Accepted Answer

Valuation multiples move with two inputs: the numerator (market capitalisation, which tracks the share price) and the denominator (book value). Share-price changes — driven by interest rates, earnings expectations, risk appetite, and broader market sentiment — typically dominate short-term moves, while changes in the underlying fundamental drive the longer-term trend. As a result, the ratio can rise during stock-price rallies even if the business itself has not become more valuable, and fall during sell-offs even when fundamentals are improving.


2025	$110.09B	$18.47B	6.0×	-1.1×	Dec 31, 2025
2024	$114.76B	$16.34B	7.0×	+3.5×	Dec 31, 2024
2023	$104.01B	$29.43B	3.5×	-1.3×	Dec 31, 2023
2022	$151.67B	$31.06B	4.9×	+1.1×	Dec 31, 2022
2021	$134.24B	$35.95B	3.7×	+0.0×	Dec 31, 2021
2020	$139.69B	$37.82B	3.7×	+1.3×	Dec 31, 2020
2019	$122.90B	$51.60B	2.4×	-3.7×	Dec 31, 2019
2018	$84.83B	$14.03B	6.0×	-2.5×	Dec 31, 2018
2017	$100.25B	$11.74B	8.5×	+2.5×	Dec 31, 2017
2016	$97.71B	$16.18B	6.0×	-1.9×	Dec 31, 2016
2015	$113.44B	$14.27B	8.0×	+1.4×	Dec 31, 2015
2014	$97.99B	$14.85B	6.6×	+0.8×	Dec 31, 2014
2013	$87.59B	$15.15B	5.8×	+1.8×	Dec 31, 2013
2012	$53.58B	$13.62B	3.9×	+0.2×	Dec 31, 2012
2011	$59.59B	$15.96B	3.7×	+0.9×	Dec 31, 2011
2010	$45.20B	$15.71B	2.9×	-0.5×	Dec 31, 2010
2009	$49.46B	$14.84B	3.3×	-0.4×	Dec 31, 2009
2008	$46.03B	$12.24B	3.8×	-1.2×	Dec 31, 2008
2007	$52.40B	$10.56B	5.0×	-0.2×	Dec 31, 2007
2006	$51.67B	$9.99B	5.2×	+1.2×	Dec 31, 2006
2005	$44.93B	$11.21B	4.0×	-0.9×	Dec 31, 2005
2004	$49.83B	$10.20B	4.9×	-0.8×	Dec 31, 2004
2003	$55.48B	$9.79B	5.7×	-0.1×	Dec 31, 2003
2002	$50.49B	$8.76B	5.8×	-5.1×	Dec 31, 2002
2001	$98.79B	$9.07B	10.9×	—	Dec 31, 2001


Quest Diagnostics (DGX)	2.9×
Moderna (MRNA)	2.7×
Charles River (CRL)	2.6×
Regeneron Pharmaceuticals (REGN)	2.6×
Henry Schein (HSIC)	2.5×
Labcorp Holdings (LH)	2.5×
Danaher (DHR)	2.4×
UnitedHealth Group (UNH)	2.4×
Solventum (SOLV)	2.3×
Becton, Dickinson and (BDX)	1.8×
Pfizer (PFE)	1.8×
Molina Healthcare (MOH)	1.7×
Cigna (CI)	1.7×
Waters Corporation (WAT)	1.6×
Cooper Companies (COO)	1.5×
Elevance Health (ELV)	1.5×
Universal Health Services (UHS)	1.5×
Biogen (BIIB)	1.4×
Baxter International (BAX)	1.4×
Revvity (RVTY)	1.4×
Zimmer Biomet Holdings (ZBH)	1.2×
CVS Health (CVS)	1.2×
Humana (HUM)	1.1×
Viatris (VTRS)	1.1×
Centene (CNC)	0.8×

P/B Ratio for Bristol-Myers Squibb (BMY)

P/B Ratio daily chart for Bristol-Myers Squibb (BMY)

Historical P/B Ratio for Bristol-Myers Squibb (BMY) from 2001 to 2025

About P/B Ratio at Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb P/B Ratio by Year

Bristol-Myers Squibb P/B Ratio 2025: 6.0×

Bristol-Myers Squibb P/B Ratio 2024: 7.0×

Bristol-Myers Squibb P/B Ratio 2023: 3.5×

Bristol-Myers Squibb P/B Ratio 2022: 4.9×

Bristol-Myers Squibb P/B Ratio 2021: 3.7×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

Bristol-Myers Squibb (BMY) Key Financials

P/B Ratio daily chart for Bristol-Myers Squibb (BMY)

Historical P/B Ratio for Bristol-Myers Squibb (BMY) from 2001 to 2025

About P/B Ratio at Bristol-Myers Squibb (BMY)

Bristol-Myers Squibb P/B Ratio by Year

Bristol-Myers Squibb P/B Ratio 2025: 6.0×

Bristol-Myers Squibb P/B Ratio 2024: 7.0×

Bristol-Myers Squibb P/B Ratio 2023: 3.5×

Bristol-Myers Squibb P/B Ratio 2022: 4.9×

Bristol-Myers Squibb P/B Ratio 2021: 3.7×

Sector peers by P/B Ratio — chart

Sector peers by P/B Ratio — table

Frequently asked questions

+What is Bristol-Myers Squibb's P/B ratio?

+How is the P/B ratio calculated?

+What is the P/B ratio?

+What is a good P/B ratio for Bristol-Myers Squibb?

+Is Bristol-Myers Squibb's P/B ratio high or low?

+What is Bristol-Myers Squibb's historical P/B ratio range?

+What was Bristol-Myers Squibb's P/B ratio in 2025?

+Why does Bristol-Myers Squibb's P/B ratio change over time?

Bristol-Myers Squibb (BMY) Key Financials